Article Details

PCSK9 affects antitumor immunity

Retrieved on: 2021-04-22 14:15:00

Tags for this article:

Click the tags to see associated articles and topics

PCSK9 affects antitumor immunity. View article details on hiswai:

Excerpt

Monoclonal antibodies Repatha (evolocumab; Amgen) and Praluent (alirocumab; Sanofi/Regeneron Pharmaceuticals) bind to PCSK9, blocking its ...

Article found on: www.bioworld.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up